Literature DB >> 4926715

Dietary migraine and tyramine metabolism.

I Smith, A H Kellow, P E Mullen, E Hanington.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1971        PMID: 4926715     DOI: 10.1038/230246a0

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


× No keyword cloud information.
  11 in total

Review 1.  A basis for migraine therapy- the autonomic theory reappraised.

Authors:  E S Johnson
Journal:  Postgrad Med J       Date:  1978-04       Impact factor: 2.401

2.  Migraine in general practice.

Authors:  K Dalton
Journal:  J R Coll Gen Pract       Date:  1973-02

3.  Migraine--a personal view.

Authors:  K Dalton
Journal:  Proc R Soc Med       Date:  1973-03

4.  The physiological role of L-tyrosine methyl ester sulphotransferase.

Authors:  D J Barford; J G Jones
Journal:  Biochem J       Date:  1971-12       Impact factor: 3.857

5.  High incidence of endogenous depression in migraine: confirmation by tyramine test.

Authors:  J Jarman; M Fernandez; P T Davies; V Glover; T J Steiner; C Thompson; F C Rose; M Sandler
Journal:  J Neurol Neurosurg Psychiatry       Date:  1990-07       Impact factor: 10.154

6.  Decreased conjugated tyramine outputs in depression: gastrointestinal factors.

Authors:  S B Carter; M Sandler; P Sepping; P K Bridges
Journal:  Br J Clin Pharmacol       Date:  1978-03       Impact factor: 4.335

7.  Metabolism of isoprenaline in dog and man.

Authors:  M E Conolly; D S Davies; C T Dollery; C D Morgan; J W Paterson; M Sandler
Journal:  Br J Pharmacol       Date:  1972-11       Impact factor: 8.739

8.  The conjugation of tyramine with sulphate by liver and intestine of different animals.

Authors:  K P Wong
Journal:  Biochem J       Date:  1976-12-15       Impact factor: 3.857

9.  The effect of ascorbic acid on the sulphate conjugation of ingested noradrenaline and dopamine.

Authors:  J W Dunne; L Davidson; R Vandongen; L J Beilin; A M Tunney; P B Rogers
Journal:  Br J Clin Pharmacol       Date:  1984-03       Impact factor: 4.335

Review 10.  Pizotifen (BC-105): a review of its pharmacological properties and its therapeutic efficacy in vascular headaches.

Authors:  T M Speight; G S Avery
Journal:  Drugs       Date:  1972       Impact factor: 9.546

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.